Cocrystal Pharma, Inc. Overview
Pro stress-test →Cocrystal Pharma is a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments. The company focuses on creating first- and best-in-class antiviral drugs targeting unmet medical needs in areas such as hepatitis, influenza, and norovirus infections.
Strategic Profile
Pro stress-test →At the heart of Cocrystal's operations is its proprietary structure-based drug design platform, which allows the company to efficiently develop small-molecule antiviral therapeutics that are safe, effective, and convenient to administer. The company has garnered strategic investments from prominent industry players, including Teva Pharmaceuticals, OPKO Health, and the Frost Group.
Competitive Landscape
Pro stress-test →Cocrystal differentiates through structure-based drug design and focus on high-impact therapeutic areas, competing against established pharmaceutical giants and emerging biotech firms, with its innovative technologies and partnerships providing unique advantages.
Industry Context
Cocrystal Pharma, Inc. operates in Biotechnology - Antiviral Therapeutics.
Key facts
Founded: 2006 · Headquarters: Bothell, Washington · Revenue: $0 · Market cap: $10M - $20M